Abstract | BACKGROUND: OBJECTIVE: To perform a detailed qualitative review of existing literature on the association of abnormal bleeding with the use of SSRIs. DATA SOURCES: We conducted a PubMed search during June 2009 using the search terms antidepressants and SSRIs (including the names of individual SSRIs: fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram) in association with bleeding, platelets, hemostasis, nonsteroidal anti-inflammatory drugs ( NSAIDs), aspirin, antiplatelet drugs, proton pump inhibitors, peptic ulcer, premenstrual dysphoric disorder, menstruation, pregnancy, postpartum hemorrhage, surgery, tooth extraction, dental bleeding, stroke, ischemic heart disease, and other terms related to the field. We then searched the reference lists of identified studies. STUDY SELECTION: We provide a qualitative discussion of all studies that would inform clinicians about the mechanisms of bleeding and bleeding risks associated with these drugs in different clinical contexts. RESULTS: CONCLUSIONS: On the basis of the findings of our literature search, we suggest that SSRI-induced increase in gastric acid secretion may explain the GI bleeding risk and that SSRI-related effects on platelet reactivity, endothelial reactivity, and inflammatory markers may explain the ischemic heart disease protective effect. Because the absolute risk of GI bleeds with SSRIs is low, precautions are probably necessary only in high-risk patients, such as those with acid-peptic disease and those with a history of bleeds. We discuss management issues and areas for future research.
|
Authors | Chittaranjan Andrade, Surya Sandarsh, Kumar B Chethan, Koregala S Nagesh |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 71
Issue 12
Pg. 1565-75
(Dec 2010)
ISSN: 1555-2101 [Electronic] United States |
PMID | 21190637
(Publication Type: Journal Article, Review)
|
Copyright | © Copyright 2010 Physicians Postgraduate Press, Inc. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Anticoagulants
- Antidepressive Agents, Second-Generation
- Platelet Aggregation Inhibitors
- Proton Pump Inhibitors
- Serotonin Uptake Inhibitors
|
Topics |
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects)
- Anticoagulants
(adverse effects)
- Antidepressive Agents, Second-Generation
(adverse effects)
- Comorbidity
- Fibrosis
(complications, epidemiology)
- Gastrointestinal Hemorrhage
(etiology, prevention & control)
- Hemorrhage
(chemically induced, epidemiology, etiology, prevention & control)
- Humans
- Liver Failure
(complications, epidemiology)
- Platelet Aggregation Inhibitors
(adverse effects)
- Practice Guidelines as Topic
- Proton Pump Inhibitors
(adverse effects)
- Risk Factors
- Selective Serotonin Reuptake Inhibitors
(adverse effects)
|